Skip to content

Clinical Trial: Accelerated Recovery Protocol in Patients Undergoing Bariatric Surgery

Clinical Trial: Accelerated Recovery Protocol in Patients Undergoing Bariatric Surgery. Randomized Comparative Study Between Usual Acceleration Protocols and the One Currently Used in the Institution (SAMSURP) - BARIMORP - BARIatric santa Marcelina Operational Recovery Protocol BARIMORP - BARIatric santa Marcelina Operational Recovery Protocol

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7hfd5rc
Enrollment
Unknown
Registered
2022-04-20
Start date
2021-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unspecified obesity

Interventions

Patients will be randomly allocated into 3 different groups through a specific program for randomization of samples, respecting the 1:1:1 ratio, with 40 individuals in each group: Traditional Recovery
Early recovery protocol called Santa Marcelina Recovery Program (PROSM), with multimodal anesthesia, early physical therapy, abbreviation of pre and postoperative fasting, in addition to the applicati
and the third group with the PROSM protocol, but with PTAS-placebo, consisting of a saline solution with 20 ml of 8.4% sodium bicarbonate.
38836

Sponsors

Casa de Saúde Santa Marcelina
Lead Sponsor
Casa de Saúde Santa Marcelina
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients aged between 18 and 60 years; able to read, understand and sign the consent form; undergoing the first procedure for the treatment of obesity

Exclusion criteria

Exclusion criteria: patients with a BMI above 60 kg/m2; patients with chronic pain with continuous use of medications for pain control, such as fibromyalgia and non-eventual low back pain; patients with heart and coronary diseases; ventricular ejection fraction less than 50%; anticoagulation with warfarin; patients with chronic kidney disease on dialysis; patients with mobility and ambulation difficulties; prolonged surgical time (greater than 3 hours) or need for conversion to open surgery; patients referred to the intensive care unit (ICU) after the procedure; need for drainage of the abdominal cavity; latex allergy; allergy to any of the medications used in the protocol

Design outcomes

Primary

MeasureTime frame
Expected Outcome: Impact of the intervention on the length of stay, assessed through data from the medical record, with an expected decrease of 25% in the length of stay in the hospital, measured in hours.

Secondary

MeasureTime frame
Expected Outcome 1: Impact of the intervention on postoperative analgesia, measured using a visual scale.;Expected outcome 2: possible change in the incidence rate of postoperative nausea and vomiting events, measured by the postoperative nausea and vomiting scale, during the hospitalization period;Expected outcome 3: possible changes in complication rates, as measured by the Clavien-Dindo (CD) classification, in the first 90 days after surgery. These will be separated into minor (CD I - II) and major (CD III - V) in order to refine the analysis.;Expected outcome 4: assessment of the rate of the number of times the patient returns to the emergency room compared to the number of patients operated on, in the first 90 days after surgery;Expected outcome 5: assessment of the rate of the number of times the patient is readmitted compared to the number of patients operated on, in the first 90 days after surgery;Expected outcome 6: assessment of the rate of the number of times the patient is reoperated compared to the number of patients operated on, in the first 90 days after surgery;Expected Outcome 7: Assessment of subjective patient satisfaction using a decimal scale within the first ninety days, measured at 2 moments, at discharge and 90 days after surgery

Countries

Brazil

Contacts

Public ContactMarcos Gouveia de Oliveira

Casa de Saúde Santa Marcelina

marcosmed97@gmail.com+5511993541608

Outcome results

None listed

Source: REBEC (via WHO ICTRP)